Search Results 1011-1020 of 13902 for Assay

  1. Claudin18.2 CAR-T (CT041) in Patients With Gastric, Pancreatic Cancer, or Other Specified Digestive Cancers - Mayo Clinic

    ... assay; 4. Failed or been intolerant of prior lines of systemic therapy; 5. Estimated life expectancy > 4 months; 6. At least 1 measurable lesion per RECIST ...

  2. Minnesota Partnership awards five collaborative research grants for 2023 - Mayo Clinic News Network

    Towards a Center for Advanced Synucleinopathy Diagnostics (ASCEND): Development and optimization of nanoparticle-enhanced seed amplification assays for blood- ...

  3. Mayo Clinic to sequence 100K participants to build genomic database for improved care and research in collaboration with Helix

    Powered by their proprietary Exome+™ assay — a panel-grade clinical exome enhanced by more than 300,000 informative non-coding regions — Helix partners with ...

  4. Cardiac Amyloidosis Clinic - Overview

    Developed assays. Secured many patents. Talk with your doctor about advances in diagnosis and treatment that might help you. Ask if you might be eligible ...

  5. A Study to Evaluate a Standard-dose and High- dose Regimen of Encorafenib + Binimetinib in Patients with BRAFV600-mutant Melanoma Brain Metastasis - Mayo Clinic

    Presence of BRAFV600 mutation in tumor tissue previously determined by a local PCR or NGS-based assay at any time prior to Screening or by a central laboratory ...

  6. Biospecimens analysis in healthy controls - Mayo Clinic

    The purpose of this study is to collect healthy patient samples and give us a normal patient levels of antibodies, cytokines and other meaningful biomarkers ...

  7. Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma (KarMMa) - Mayo Clinic

    Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. Recovery to Grade 1 or ...

  8. Analysis of Blood and Urine for Microbial Pathogen Discovery and Undiagnosed Infection - Mayo Clinic

    The aim of this study is to identify difficult to diagnose microbial pathogens causing infections using blood or urine for identification of bacteria, viruses, ...

  9. Cholangiocarcinoma Clinical Trials - Mayo Clinic Research

    cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease (CAMPERR) Rochester, MN. The purpose of this ...

  10. Kidney Cancer Clinical Trials - Mayo Clinic Research

    GRAIL is using deep sequencing of circulating cell-free nucleic acids (cfNAs) to develop assays to detect cancer early in blood. The purpose of this study is to ...